IN187837B - - Google Patents

Info

Publication number
IN187837B
IN187837B IN1090MA1998A IN187837B IN 187837 B IN187837 B IN 187837B IN 1090MA1998 A IN1090MA1998 A IN 1090MA1998A IN 187837 B IN187837 B IN 187837B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Andrew Day
Huw Lyn Jones
Carl Simon Smith
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of IN187837B publication Critical patent/IN187837B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1090MA1998 1997-05-22 1998-05-21 IN187837B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9710521.7A GB9710521D0 (en) 1997-05-22 1997-05-22 Process

Publications (1)

Publication Number Publication Date
IN187837B true IN187837B (de) 2002-06-29

Family

ID=10812840

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1090MA1998 IN187837B (de) 1997-05-22 1998-05-21

Country Status (31)

Country Link
US (1) US6194003B1 (de)
EP (1) EP0983059B1 (de)
JP (1) JP2001527567A (de)
KR (1) KR20010012739A (de)
CN (1) CN1154480C (de)
AR (1) AR015812A1 (de)
AT (1) ATE245021T1 (de)
AU (1) AU725760B2 (de)
BG (1) BG103881A (de)
BR (1) BR9809651A (de)
CA (1) CA2290830C (de)
CZ (1) CZ290816B6 (de)
DE (1) DE69816440T2 (de)
DK (1) DK0983059T3 (de)
ES (1) ES2202871T3 (de)
GB (1) GB9710521D0 (de)
HU (1) HU224954B1 (de)
ID (1) ID22949A (de)
IL (1) IL132999A0 (de)
IN (1) IN187837B (de)
MY (1) MY118410A (de)
NO (1) NO995681D0 (de)
NZ (1) NZ500664A (de)
PL (1) PL190947B1 (de)
PT (1) PT983059E (de)
RU (1) RU2203046C2 (de)
SK (1) SK283701B6 (de)
TR (1) TR199902725T2 (de)
UA (1) UA53714C2 (de)
WO (1) WO1998052539A1 (de)
ZA (1) ZA984260B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0016236A (pt) 1999-12-09 2002-12-24 Boots Co Plc Agentes terapêuticos
EP1284729A4 (de) * 2000-04-13 2007-12-19 Mayo Foundation A-(beta)-42 senkende arzneimittel
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
EP1603548A4 (de) * 2003-02-05 2007-10-10 Myriad Genetics Inc Verfahren und zusammensetzung zur behandlung neurodegenerativer erkrankungen
EP1651195A4 (de) * 2003-07-11 2007-10-03 Myriad Genetics Inc Pharmazeutische verfahren, dosierschemata und dosierformen zur behandlung von alzheimerkrankheit
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
EP1745180A1 (de) * 2004-04-29 2007-01-24 Keystone Retaining Wall Systems, Inc. Frontverkleidung für stützwände
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
AU2006211023B2 (en) 2005-02-03 2012-05-24 Takeda Nycomed As Fast wet-massing method for the preparation of calcium-containing compositions
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
BRPI0613611A2 (pt) * 2005-07-22 2011-01-18 Myriad Genetics Inc formulações de alta concentração de fármaco e formas de dosagens
RU2008116871A (ru) * 2005-11-02 2009-12-10 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. (US) Органолептически приемлемые пероральные лекарственные формы ибупрофена, способы их приготовления и применения
EP2046119A2 (de) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Behandlung von psychiatrischen störungen
EP2170063A1 (de) * 2007-07-23 2010-04-07 Teikoku Pharma USA, Inc. Organoleptisch akzeptable orale dosierungsformulierungen eines indol-serotonin-rezeptoragonisten und anwendungsverfahren dafür
EP2328549B1 (de) * 2008-08-22 2017-11-15 Reckitt Benckiser Healthcare (UK) Limited Zusammensetzungen gegen halsschmerzen
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
CA2860373C (en) 2011-04-29 2017-08-15 Moberg Pharma Ab Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat
EP2609911A1 (de) * 2011-12-29 2013-07-03 Sanovel Ilac Sanayi ve Ticaret A.S. Neuartiges Verfahren zur Herstellung von oral zerfallenden Flurbiprofen-Formulierungen
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
WO2017029710A1 (ja) * 2015-08-18 2017-02-23 合同会社Ｐｈａｒｍａ Ｓｅｅｄｓ Ｃｒｅａｔｅ ＮＳＡＩＤｓまたはヘパリン類含有口腔用組成物
WO2020013781A2 (en) * 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5614207A (en) * 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
US6194003B1 (en) 2001-02-27
SK158899A3 (en) 2000-05-16
BG103881A (en) 2000-05-31
HUP0002121A3 (en) 2001-04-28
NO995681L (no) 1999-11-19
NZ500664A (en) 2001-01-26
CA2290830C (en) 2006-07-11
AU725760B2 (en) 2000-10-19
PL190947B1 (pl) 2006-02-28
ES2202871T3 (es) 2004-04-01
DK0983059T3 (da) 2003-11-03
ID22949A (id) 1999-12-16
DE69816440T2 (de) 2004-05-13
NO995681D0 (no) 1999-11-19
SK283701B6 (sk) 2003-12-02
WO1998052539A1 (en) 1998-11-26
CA2290830A1 (en) 1998-11-26
MY118410A (en) 2004-10-30
CN1154480C (zh) 2004-06-23
BR9809651A (pt) 2000-07-11
CZ290816B6 (cs) 2002-10-16
ATE245021T1 (de) 2003-08-15
DE69816440D1 (de) 2003-08-21
ZA984260B (en) 1999-02-20
TR199902725T2 (xx) 2000-02-21
UA53714C2 (uk) 2003-02-17
PL336624A1 (en) 2000-07-03
AR015812A1 (es) 2001-05-30
CZ412099A3 (cs) 2000-02-16
AU7916598A (en) 1998-12-11
KR20010012739A (ko) 2001-02-26
CN1255848A (zh) 2000-06-07
HU224954B1 (en) 2006-04-28
EP0983059A1 (de) 2000-03-08
RU2203046C2 (ru) 2003-04-27
IL132999A0 (en) 2001-03-19
PT983059E (pt) 2003-11-28
GB9710521D0 (en) 1997-07-16
EP0983059B1 (de) 2003-07-16
HUP0002121A2 (hu) 2000-12-28
JP2001527567A (ja) 2001-12-25

Similar Documents

Publication Publication Date Title
BE2018C032I2 (de)
IN189317B (de)
ITRM970365A0 (de)
CH0944937H2 (de)
IN186870B (de)
ITMI971203A0 (de)
JP2001116613A5 (de)
IN185742B (de)
ITRM970291A0 (de)
ITVI970057A0 (de)
BR9701757A (de)
ITRM970385A0 (de)
IN190394B (de)
ITTO970116V0 (de)
ITMI970957A0 (de)
IN192799B (de)
IN189106B (de)
BR9700653A (de)
CN3058057S (de)
BY4349C1 (de)
CN3054556S (de)
CN3054902S (de)
CN3054099S (de)
CN3053500S (de)
CN3055123S (de)